Alkermes Plc
NASDAQ:ALKS

Watchlist Manager
Alkermes Plc Logo
Alkermes Plc
NASDAQ:ALKS
Watchlist
Price: 31.42 USD 0.67% Market Closed
Market Cap: 5.2B USD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

ALKS Price Targets Summary
Alkermes Plc

Wall Street analysts forecast ALKS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ALKS is 40.56 USD with a low forecast of 30.3 USD and a high forecast of 54.6 USD.

ALKS Lowest Forecast
Wall Street Target
30.3 USD
4% Downside
ALKS Average Forecast
Wall Street Target
40.56 USD
29% Upside
ALKS Highest Forecast
Wall Street Target
54.6 USD
74% Upside
Lowest
Price Target
30.3 USD
4% Downside
Average
Price Target
40.56 USD
29% Upside
Highest
Price Target
54.6 USD
74% Upside
Alkermes Plc Competitors:
Price Targets
VITR
Vitrolife AB
46% Upside
ACAD
ACADIA Pharmaceuticals Inc
11% Upside
S
6955
Shandong Boan Biotechnology Co Ltd
11% Upside
NBIX
Neurocrine Biosciences Inc
31% Upside
VITR
Vitrolife AB
46% Upside
ACAD
ACADIA Pharmaceuticals Inc
11% Upside
S
6955
Shandong Boan Biotechnology Co Ltd
11% Upside
NBIX
Neurocrine Biosciences Inc
31% Upside
BMRN
Biomarin Pharmaceutical Inc
65% Upside
STOK
Stoke Therapeutics Inc
150% Upside
ITOS
Iteos Therapeutics Inc
227% Upside
S
688293
Shanghai OPM Biosciences Co Ltd
33% Upside

Revenue
Forecast

Revenue Estimate
Alkermes Plc

For the last 8 years the compound annual growth rate for Alkermes Plc's revenue is 10%. The projected CAGR for the next 3 years is -2%.

10%
Past Growth
-2%
Estimated Growth
Estimates Accuracy
-1%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Alkermes Plc

The compound annual growth rate of Alkermes Plc's operating income for the next 3 years is -24%.

N/A
Past Growth
-24%
Estimated Growth
Estimates Accuracy
-4%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Alkermes Plc

The compound annual growth rate of Alkermes Plc's net income for the next 3 years is -12%.

N/A
Past Growth
-12%
Estimated Growth
Estimates Accuracy
27%
Average Beat
What are analyst estimates?

See Also

Summary
ALKS intrinsic value, competitors valuation, and company profile.
DCF Valuation
ALKS stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ALKS stock valuation using valuation multiples.
Wall Street Estimates
ALKS price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ALKS stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ALKS's stock price target?
Price Target
40.56 USD

According to Wall Street analysts, the average 1-year price target for ALKS is 40.56 USD with a low forecast of 30.3 USD and a high forecast of 54.6 USD.

What is Alkermes Plc's Revenue forecast?
Projected CAGR
-2%

For the last 8 years the compound annual growth rate for Alkermes Plc's revenue is 10%. The projected CAGR for the next 3 years is -2%.

What is Alkermes Plc's Operating Income forecast?
Projected CAGR
-24%

The compound annual growth rate of Alkermes Plc's operating income for the next 3 years is -24%.

What is Alkermes Plc's Net Income forecast?
Projected CAGR
-12%

The compound annual growth rate of Alkermes Plc's net income for the next 3 years is -12%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 255,600+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.